Stay updated with breaking news from Crown Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Dermatology Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering....
/PRNewswire/ -- The "Global Cardiovascular Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's...
/PRNewswire/ -- After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics...
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, announced today that it has completed its acquisition of the IndivuServ business unit of Indivumed GmbH
In 2021, the global Oncology-based In-vivo CRO Market was estimated to be worth around $1 billion. With a projected CAGR of 10.9% over the next ten years, the market is expected to be worth nearly US$ 2.9 billion by the end of 2033. By 2033, the absolute dollar opportunity in the Oncology-based In-vivo CRO Market is...